Answers are grounded in this paper and cite their sources.
We report occurrence of severe methemoglobinemia in a patient on novel experimental anti-cancer drug, Triapine. Treatment with methylene blue led to massive hemolysis due to concomitant G6PD deficiency. We recommend that G6PD screening be done in high-risk populations prior to commencement of Triapine therapy.
No takes yet. Share an insight, caveat, or question.
Foltz et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: